4//SEC Filing
Powell Fred M 4
Accession 0001016169-22-000014
CIK 0001016169other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:16 PM ET
Size
6.9 KB
Accession
0001016169-22-000014
Insider Transaction Report
Form 4
Powell Fred M
Senior Vice President & CFO
Transactions
- Award
Common Stock
2022-02-16+24,606→ 786,258 total - Tax Payment
Common Stock
2022-02-16$3.66/sh−11,496$42,075→ 774,762 total
Footnotes (1)
- [F1]On June 13, 2019, Mr. Powell was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three-year performance period ended December 31, 2021. The number of shares acquired represent the total number of shares earned upon achievement of one of the performance goals, which was certified and vested on February 16, 2022. The shares of common stock disposed represents the number of shares withheld by the company to settle tax liabilities in connection with the vesting of the performance stock unit award and were not actually sold.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001331339
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:16 PM ET
- Size
- 6.9 KB